• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PXT261414
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 01/11/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This event also includes device (b)(4).
 
Event or Problem Description
On (b)(6) 2004, the patient was treated for an abdominal aortic aneurysm.The physician implanted three gore® excluder® aaa endoprostheses.The patient tolerated the procedure.On (b)(6) 2022, the patient underwent a reintervention.A type ia endoleak was suspected between the renals and the proximal end of the main body of the graft.The endoleak could not be confirmed, but a gore® excluder® aaa endoprosthesis was implanted as a precaution.In addition, at type iii endoleak was suspected between the distal end of the main body and one of the contralateral leg segments, (unknown which one).Again, the endoleak was not confirmed, but as a precaution, two gore® excluder® aaa endoprostheses were implanted.The patient tolerated the procedure.
 
Additional Manufacturer Narrative
H.6.Investigation findings: code 3233 updated to code 213.H.6.Investigation conclusions: code 11 updated to code 4315.H.6.Type of investigation code 4118 updated to code 3331 with completion of phr review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
greg rawlings
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key13453423
Report Number2017233-2022-02713
Device Sequence Number5785465
Product Code MIH
UDI-Device Identifier00733132610228
UDI-Public00733132610228
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2004
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/30/2007
Device Model NumberPXT261414
Device Catalogue NumberPXT261414
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/11/2022
Supplement Date Received by Manufacturer01/11/2022
Initial Report FDA Received Date02/04/2022
Supplement Report FDA Received Date05/23/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/13/2004
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age86 YR
Patient SexMale
-
-